Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Aortic Valve Stenosis | 9 | 2019 | 741 | 1.47 | Why? |
| Stents | 5 | 2017 | 916 | 1.03 | Why? |
| Drug-Eluting Stents | 5 | 2019 | 562 | 0.88 | Why? |
| Whole Blood Coagulation Time | 1 | 2019 | 10 | 0.83 | Why? |
| Radial Artery | 1 | 2019 | 132 | 0.72 | Why? |
| Heart Valve Prosthesis | 4 | 2019 | 533 | 0.71 | Why? |
| Transcatheter Aortic Valve Replacement | 7 | 2019 | 839 | 0.68 | Why? |
| Angioplasty, Balloon, Coronary | 2 | 2017 | 365 | 0.65 | Why? |
| Atrial Appendage | 1 | 2018 | 120 | 0.64 | Why? |
| Angioplasty, Balloon | 1 | 2017 | 66 | 0.64 | Why? |
| Percutaneous Coronary Intervention | 6 | 2019 | 3646 | 0.62 | Why? |
| Catheterization, Peripheral | 1 | 2019 | 249 | 0.61 | Why? |
| Coronary Aneurysm | 1 | 2017 | 132 | 0.60 | Why? |
| Purinergic P2Y Receptor Antagonists | 1 | 2017 | 206 | 0.58 | Why? |
| Platelet Aggregation Inhibitors | 4 | 2019 | 1671 | 0.57 | Why? |
| Aortic Valve | 5 | 2019 | 664 | 0.56 | Why? |
| Arterial Occlusive Diseases | 1 | 2019 | 363 | 0.56 | Why? |
| Prosthesis Design | 7 | 2019 | 594 | 0.55 | Why? |
| Embolization, Therapeutic | 1 | 2017 | 269 | 0.54 | Why? |
| Coronary Stenosis | 1 | 2017 | 273 | 0.53 | Why? |
| Heart Valve Prosthesis Implantation | 2 | 2017 | 552 | 0.52 | Why? |
| Carotid Artery Diseases | 1 | 2017 | 251 | 0.52 | Why? |
| Hemostasis | 1 | 2019 | 811 | 0.50 | Why? |
| Coronary Artery Disease | 6 | 2019 | 2570 | 0.48 | Why? |
| Coronary Disease | 1 | 2017 | 645 | 0.43 | Why? |
| Embolic Protection Devices | 3 | 2017 | 16 | 0.39 | Why? |
| Colchicine | 3 | 2021 | 730 | 0.38 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.37 | Why? |
| Sirolimus | 2 | 2019 | 240 | 0.32 | Why? |
| Absorbable Implants | 2 | 2019 | 191 | 0.30 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.28 | Why? |
| Carotid Stenosis | 2 | 2017 | 207 | 0.27 | Why? |
| Coronary Thrombosis | 2 | 2021 | 433 | 0.27 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.26 | Why? |
| Treatment Outcome | 20 | 2021 | 51732 | 0.26 | Why? |
| Thrombosis | 3 | 2021 | 7504 | 0.25 | Why? |
| Endovascular Procedures | 3 | 2017 | 1302 | 0.25 | Why? |
| Anticoagulants | 3 | 2019 | 9563 | 0.23 | Why? |
| Coronary Angiography | 5 | 2020 | 2275 | 0.22 | Why? |
| Coronary Vessels | 2 | 2017 | 914 | 0.20 | Why? |
| Punctures | 1 | 2019 | 89 | 0.20 | Why? |
| Vascular Patency | 1 | 2019 | 96 | 0.20 | Why? |
| Polymers | 3 | 2019 | 507 | 0.19 | Why? |
| Tubulin Modulators | 1 | 2020 | 126 | 0.19 | Why? |
| Computed Tomography Angiography | 2 | 2018 | 2153 | 0.17 | Why? |
| Radiation Monitoring | 1 | 2017 | 25 | 0.17 | Why? |
| Postoperative Hemorrhage | 1 | 2019 | 183 | 0.17 | Why? |
| Troponin | 2 | 2020 | 1058 | 0.16 | Why? |
| Graft vs Host Disease | 1 | 2021 | 501 | 0.16 | Why? |
| Equipment Failure | 1 | 2018 | 197 | 0.16 | Why? |
| Aortic Valve Insufficiency | 1 | 2018 | 136 | 0.16 | Why? |
| Intracranial Embolism | 1 | 2017 | 73 | 0.16 | Why? |
| Coronary Occlusion | 1 | 2018 | 138 | 0.15 | Why? |
| Postoperative Complications | 3 | 2018 | 5861 | 0.14 | Why? |
| Troponin I | 2 | 2020 | 1298 | 0.14 | Why? |
| Radiation Exposure | 1 | 2017 | 161 | 0.14 | Why? |
| Acute Coronary Syndrome | 2 | 2019 | 2107 | 0.14 | Why? |
| Echocardiography, Transesophageal | 1 | 2018 | 447 | 0.14 | Why? |
| Time Factors | 10 | 2020 | 31397 | 0.14 | Why? |
| Coronary Artery Bypass | 2 | 2019 | 629 | 0.13 | Why? |
| ST Elevation Myocardial Infarction | 2 | 2021 | 3051 | 0.13 | Why? |
| Predictive Value of Tests | 5 | 2020 | 9537 | 0.13 | Why? |
| Drug Administration Schedule | 2 | 2020 | 2324 | 0.13 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.13 | Why? |
| Pulmonary Artery | 1 | 2020 | 803 | 0.13 | Why? |
| Heart Valve Diseases | 1 | 2018 | 355 | 0.13 | Why? |
| Risk Factors | 13 | 2020 | 71621 | 0.13 | Why? |
| Registries | 5 | 2020 | 12327 | 0.12 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.12 | Why? |
| Heart Diseases | 2 | 2020 | 3503 | 0.12 | Why? |
| Randomized Controlled Trials as Topic | 5 | 2020 | 10649 | 0.12 | Why? |
| Myocardial Infarction | 3 | 2017 | 3361 | 0.12 | Why? |
| Diffusion of Innovation | 1 | 2017 | 440 | 0.12 | Why? |
| Radiation Dosage | 1 | 2017 | 585 | 0.12 | Why? |
| Program Development | 1 | 2018 | 1089 | 0.11 | Why? |
| Aged | 18 | 2020 | 215776 | 0.11 | Why? |
| Immunomodulation | 1 | 2020 | 1472 | 0.11 | Why? |
| Radiologists | 1 | 2017 | 873 | 0.10 | Why? |
| Tomography, Optical Coherence | 1 | 2017 | 1008 | 0.10 | Why? |
| Italy | 9 | 2020 | 38444 | 0.10 | Why? |
| Prospective Studies | 7 | 2020 | 43301 | 0.10 | Why? |
| Ventricular Dysfunction, Left | 1 | 2018 | 993 | 0.10 | Why? |
| Cardiac Catheterization | 1 | 2017 | 882 | 0.10 | Why? |
| Stroke | 3 | 2017 | 8839 | 0.10 | Why? |
| Drug Therapy, Combination | 3 | 2018 | 7268 | 0.10 | Why? |
| Ventricular Function, Left | 1 | 2018 | 1555 | 0.10 | Why? |
| Vascular Surgical Procedures | 1 | 2018 | 882 | 0.09 | Why? |
| Aged, 80 and over | 13 | 2020 | 88759 | 0.09 | Why? |
| Humans | 34 | 2021 | 930598 | 0.09 | Why? |
| Antihypertensive Agents | 1 | 2020 | 1962 | 0.09 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.09 | Why? |
| Male | 20 | 2020 | 367725 | 0.09 | Why? |
| Hemorrhage | 2 | 2018 | 3013 | 0.09 | Why? |
| Follow-Up Studies | 4 | 2019 | 17020 | 0.09 | Why? |
| Bayes Theorem | 1 | 2017 | 3237 | 0.08 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.08 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
| Female | 19 | 2020 | 380317 | 0.07 | Why? |
| Middle Aged | 14 | 2020 | 270681 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Atherectomy, Coronary | 1 | 2004 | 35 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Spasm | 1 | 2021 | 21 | 0.06 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.05 | Why? |
| Finite Element Analysis | 1 | 2019 | 27 | 0.05 | Why? |
| Heparin Antagonists | 1 | 2019 | 21 | 0.05 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.05 | Why? |
| Retroperitoneal Space | 1 | 2019 | 68 | 0.05 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
| Models, Cardiovascular | 1 | 2019 | 153 | 0.05 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.04 | Why? |
| Occupational Exposure | 1 | 2017 | 4742 | 0.04 | Why? |
| Paclitaxel | 1 | 2017 | 124 | 0.04 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2019 | 226 | 0.04 | Why? |
| Everolimus | 1 | 2018 | 215 | 0.04 | Why? |
| Ultrasonography, Doppler | 1 | 2019 | 406 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2018 | 48226 | 0.04 | Why? |
| Erythrocyte Transfusion | 1 | 2019 | 386 | 0.04 | Why? |
| Cause of Death | 2 | 2020 | 4823 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Biomedical Technology | 1 | 2018 | 257 | 0.03 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Data Accuracy | 1 | 2019 | 715 | 0.03 | Why? |
| Greece | 1 | 2020 | 2091 | 0.03 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Myocardial Ischemia | 1 | 2018 | 781 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.03 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.02 | Why? |
| Diarrhea | 1 | 2020 | 2743 | 0.02 | Why? |
| Arrhythmias, Cardiac | 1 | 2021 | 2510 | 0.02 | Why? |
| Electrocardiography | 1 | 2021 | 3957 | 0.02 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Echocardiography | 1 | 2020 | 3661 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Antirheumatic Agents | 1 | 2020 | 3023 | 0.02 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.02 | Why? |
| Computer Simulation | 1 | 2019 | 4982 | 0.02 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Models, Animal | 1 | 2004 | 788 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2019 | 6331 | 0.01 | Why? |
| Catheterization | 1 | 2003 | 264 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Safety | 1 | 2003 | 1583 | 0.01 | Why? |
| Swine | 1 | 2004 | 3352 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Cost-Benefit Analysis | 1 | 2003 | 2259 | 0.01 | Why? |
| Animals | 1 | 2004 | 78931 | 0.00 | Why? |
| Adult | 1 | 2004 | 244371 | 0.00 | Why? |
Reimers's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(150)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_